Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AngioDynamics, Inc. - Common Stock
(NQ:
ANGO
)
11.82
+0.28 (+2.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AngioDynamics, Inc. - Common Stock
< Previous
1
2
3
Next >
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List
October 13, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum
October 02, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2026 First Quarter Results on October 2, 2025
September 18, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
August 06, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
July 28, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology
July 23, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Strong Fiscal Year 2025 Fourth Quarter and Full Year Financial Results; Continued Execution Driving Accelerated, Profitable Growth
July 15, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 Fourth Quarter and Full-Year Financial Results on Tuesday, July 15, 2025
July 07, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
June 23, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results
April 02, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Host Virtual Cardiovascular Investor Event
March 31, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event
March 19, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
March 10, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
January 30, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
January 13, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
January 08, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
January 06, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
January 06, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
December 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
December 09, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
October 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
October 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
October 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
September 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
July 16, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
July 08, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today